Manufacturers OEM

Hemoteq AG

Adenauerstr. 15, 52146 Würselen

Telephone +49 2405 455000
Fax +49 2405 455012

This company is co-exhibitor of
Freudenberg Medical Europe GmbH

Trade fair hall

  • Hall 8b / H01
 Interactive Plan

Hall map

COMPAMED 2016 hall map (Hall 8b): stand H01

Fairground map

COMPAMED 2016 fairground map: Hall 8b

Our range of products

Product categories

  • 13  Services
  • 13.01  Design, Research and Development Services
  • 13.01.15  Product design and development

Product design and development

  • 13  Services
  • 13.01  Design, Research and Development Services
  • 13.01.20  Process design and development

Process design and development

Our products

Product category: Coating

Elastomeric coatings

Hemoteq addresses the growing market of devices for natural orifice surgery (NOS) and other minimal invasive procedures, e.g. stent-grafts and other covered scaffolds. Meshed structures with complex geometries can do multiple tasks: restore anatomical structures, assist compartmentalisation, prevent in-growth of tissue, correct organ dysfunction and even systemic disorders.

Based on a decade´s expertise in thin-walled elastomeric coatings on meshed structures of variable 3D complexity, we are offering custom design and manufacturing of devices covered with highly elastic, robust liners of biocompatible elastomers such as PU and silicone rubber.

The elastomeric surface can be further enhanced with special functionalities such as wet and dry lubricity or controlled release of active substances. 

More Less

Product category: Coating

Drug coatings for balloon catheters

Hemoteq has achieved pioneering work when it comes to drug coatings for balloon catheters. As one of the first companies of its kind, we have succeeded in advancing the technology of “drug-coated balloons” (DCB). Many DCB concepts developed in collaboration with prestigious customers have now been granted regulatory approval. The “drug-coated balloon" is gaining ever increasing importance on the market and is opening up new options for vascular interventions. With HemoPax™, Hemoteq is showcasing a new generation of balloon coatings that have been tailored to the specific characteristics of the drug Paclitaxel:

Drug Delivery Coatings

More Less

Product category: Coating

Systems and coatings with controlled drug delivery

In clinical practice and scientific studies, our drug coatings have been proven to improve the functionality and safety of implants. We have extensive experience in adapting our patented coating platforms, with a range of drugs, to various implant designs.

The following platforms are available to you:

Drug Eluting Stents
Drug Coated Balloons
Customized Drug Delivery Coatings

More Less

Product category: Coating

Combination products & coatings

Each coating is individually developed by Hemoteq and specifically tailored to the product.
With years of experience and a unique IP portfolio, we have proven basic concepts to develop quickly and accurately individually optimized coatings.

More Less

Product category: Coating

Lubricous coatings

Lubricous coatings on medical devices reduce the adverse effects of dynamic and static friction. The performance, accuracy and durability of products is increased.

The Lubriteq® platform allows for different degrees of lubricity:


More Less

About us

Company details

Hemoteq is the leading designer and manufacturer of customized coatings for medical devices.

Our innovative surface solutions create a sustainable competitive advantage for our clients.

A broad repertoire of unique platform technologies and a strong intellectual property portfolio allow the company to create competitive, innovative products for a wide range of clinical and biomedical applications.

Intelligent drug delivery coatings, hemocompatible surfaces and lubricious coatings lay the foundation for integrated combination products of the next generation – adaptive biodevices

Hemoteq is Your First Choice for Surface Modication.

More Less

Company data

Sales volume

10-49 Mio US $

Export content

max. 75%

Number of employees